Boehringer Pays $650 Million to End Blood-Thinner Cases

May 28, 2014 3:16 PM

6 0

Boehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths.

Boehringer, slated to face the first U.S. trial in September of claims there was no antidote to stop bleed-out deaths among Pradaxa patients, is seeking to resolve about 4,000 suits, company officials said in a statement today. That would provide an average per-case payout of $162,500.

Also read: Now a jury must unanimously agree on the death penalty in Florida, Supreme Court rules

Read more

To category page